Roche

News

Priority review sets up Feb verdict on Sanofi, Sobi haemophi...

The FDA will carry out a speedy review of Sanofi and Sobi's once-weekly haemophilia A treatment efanesoctocog alfa (Bivv001), with a decision now

News

End of the line for Sanofi's SERD amcenestrant as it fails f...

Sanofi has called time on breast cancer candidate amcenestrant – at one time one of its top pipeline prospects – after it missed the mark in another clinical trial.

News

Roche eyes April FDA verdict on Polivy as first-line lymphom...

The FDA has started a review of Roche's Polivy for people with previously untreated diffuse large B-cell lymphoma (DLBCL), as the drugmaker tries to move the drug further up the treatment p

News

Pressure rises on Lucentis, as Coherus biosimilar gets FDA n...

The US FDA has approved a new biosimilar of Roche and Novartis' blockbuster ophthalmology therapy Lucentis – Coherus BioSciences' Cimerli – which its developer claims is the first to be ful

News

Roche adds to pipeline with Poseida, Kiniksa deals

Roche has announced a pair of licensing deals with Poseida Therapeutics and Kiniksa Pharmaceuticals that bolster its pipeline in cancer and inflammatory diseases.

News

Doctor in white rubber protective gloves putting adhesive bandage on young man's arm after scratch on skin or injection of vaccine. First aid. Medical, pharmacy and healthcare concept. Closeup.

Roche scores phase 3 win for subcutaneous Tecentriq, eyes fi...

Roche's Tecentriq could become the first drug in the PD-1/PD-L1 inhibitor class to be approved in a subcutaneous formulation, after the new version matched the original intravenous formulat

Priority review sets up Feb verdict on Sanofi, Sobi haemophi...

End of the line for Sanofi's SERD amcenestrant as it fails f...

Roche eyes April FDA verdict on Polivy as first-line lymphom...

Pressure rises on Lucentis, as Coherus biosimilar gets FDA n...

Roche adds to pipeline with Poseida, Kiniksa deals

Roche scores phase 3 win for subcutaneous Tecentriq, eyes fi...

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

Roche

Editor's Picks